Drugs / FluMist®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02597647 | Feb 2011 → Apr 2014 | influenza | University of California, Los Angeles | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluMist | “administering intranasal live attenuated influenza virus (i.e., FluMist® vaccine) or saline mist to healthy subjects” NCT02597647 ↗ |
| Known as | LAIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02597647 ↗ |
| Modality | Vaccine | “live attenuated influenza vaccine” NCT02597647 ↗ |
| Route | Intranasal | “following intranasal administration of LAIV” NCT02597647 ↗ |